Ticker Symbol: RUBY
Rubius Therapeutics Inc
$13.61 - 02-12-2024 4 p.m. ET
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001709401
Company Profile
Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics™. The Company's proprietary RED PLATFORM® was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: 399 Binney St Ste 300
Website: www.rubiustx.com
CEO: Pablo Cagnoni
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.01
Change:
$0.00
(
-1.10%)
Days Range: $0.01 - $0.01
Beta: -
52wk. High: $0.11
52wk. Low: $0.00
Ytd. Change -75.16%
50 Day Moving Average: $0.01
200 Day Moving Average: $0.01
Shares Outstanding: 90482951
Valuation
Market Cap: 162.9M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A